Ling Li

22.7k citations
578 papers · 18.1k · 4 hit papers · h-index 62

Impact in

    • MicroRNA in disease regulation
    • Cancer-related molecular mechanisms research
    • Epigenetics and DNA Methylation
    • Advanced biosensing and bioanalysis techniques
    • RNA modifications and cancer

Papers in

    • Metabolism, Diabetes, and Cancer 28
    • Advanced biosensing and bioanalysis techniques 28
    • RNA modifications and cancer 20
    • RNA Interference and Gene Delivery 20
    • Cancer-related molecular mechanisms research 24

Ling Li

556 papers receiving 17.7k citations

Ling Li's Hit Papers

Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials 2021 · 492 citations
4920+8+16Years since publication200400600

Peers

Ling Li
Comparison fields: 5 of 177
  • Cancer Research 2.3k
  • Molecular Biology 7.6k
  • Endocrinology, Diabetes and Metabolism 1.5k
  • Endocrine and Autonomic Systems 519
  • Physiology 1.7k
Replace Yan Chen with:
Yan Chen China
Chih‐Yang Huang Taiwan
Xiaokun Li China
Fuu‐Jen Tsai Taiwan
Athanasios G. Papavassiliou Greece
Yan Li China
Ryuichi Morishita Japan
Subramaniam Pennathur United States
Nobuhiro Yamada Japan
Shinya Toyokuni Japan
Ling Li relative to Yan Chen China Yan Chen's profile →
Citations per field
00.5×1.5×
Yan Chen · 1×
Citations per year

Countries citing papers authored by Ling Li

Since Specialization
Citations

This map shows the geographic impact of Ling Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Li more than expected).

Fields of papers citing papers by Ling Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ling Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Li. The network helps show where Ling Li may publish in the future.

Co-authors

The 25 scholars most cited alongside Ling Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ling Li Line = papers co-authored together Ling Li links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 578 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Mitochondrial ROS promote mitochondrial dysfunction and inflammation in ischemic acute kidney injury by disrupting TFAM-mediated mtDNA maintenance
Hit paper breakdown →
2020652
2
Akt Activation Preserves Cardiac Function and Prevents Injury After Transient Cardiac Ischemia In Vivo
Hit paper breakdown →
2001623
3 2009597
4 2003550
5
Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials
Hit paper breakdown →
2021492
6 2012473
7 2018329
8 2017260
9 2014228
10 2021219
11 2015194
12 2015180
13 2007166
14 2005165
15
3D-bioprinted BMSC-laden biomimetic multiphasic scaffolds for efficient repair of osteochondral defects in an osteoarthritic rat model
Hit paper breakdown →
2021157
16 2012156
17 2007134
18 2010134
19 2014128
20 2012123

About Ling Li

Ling Li is a scholar working on Molecular Biology, Cancer Research, Epidemiology, Rheumatology and Endocrinology, Diabetes and Metabolism, having authored 578 papers that have together received 18.1k indexed citations. Recurring topics across this work include Adipokines, Inflammation, and Metabolic Diseases (38 papers), Adipose Tissue and Metabolism (30 papers), Metabolism, Diabetes, and Cancer (28 papers), Advanced biosensing and bioanalysis techniques (28 papers), Cancer-related molecular mechanisms research (24 papers), Liver Disease Diagnosis and Treatment (21 papers), RNA modifications and cancer (20 papers) and RNA Interference and Gene Delivery (20 papers). The work is most often cited by research in Cancer Research (2.3k citations), Molecular Biology (7.6k citations), Endocrinology, Diabetes and Metabolism (1.5k citations), Endocrine and Autonomic Systems (519 citations) and Physiology (1.7k citations). Ling Li has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Gangyi Yang, Mengliu Yang, Hua Liu, Guenther H. Boden, Bruce A. Edgar, Geneviève Renier, Xinsheng Gao, Leslie J. Saucedo, Jingqiu Cheng and Dongfang Liu. Their work appears in journals such as Scientific Reports, Oncotarget, Frontiers in Endocrinology, PLoS ONE and Diabetes.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact